Hyobin LLC: Drug Recall
Recall #D-0382-2021 · 04/06/2021
Class II: Risk
Recall Details
- Recall Number
- D-0382-2021
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Hyobin LLC
- Status
- Ongoing
- Date Initiated
- 04/06/2021
- Location
- Ridgewood, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 500 cards
Reason for Recall
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.
Product Description
PremierZen Black 5000, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ
Distribution Pattern
USA Nationwide
Other Recalls by Hyobin LLC
- Class II: Risk 04/06/2021
- Class II: Risk 04/06/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.